General Information
Revision date
2017-07-29
Product name
Azacitidine for Injection 100 mg/vial
Manufacturer Name
Accord Healthcare Pty Ltd
Icons in SDS
Company Information
company name
Accord Healthcare Pty Ltd
GHS Information
Signal word
None
Section 2
SECTION 2: Hazards identification
Appearance: Lyophilized powder in vial.
Signal word
None Required Hazard Overview: Contains a pharmacologically active compound currently indicated for the treatment of certain myelodysplastic syndromes. The physical, chemical, and ecological properties of this material have not been fully characterized. Exposure by any route should be minimized. Exercise due care: wear suitable protective clothing, gloves and eye/face protection. Statement of Known Hazard Contains azacitidine Probable human carcinogen. May cause hematological toxicity, gastrointestinal effects, fever, fatigue and ecchymosis. Potential reproductive/developmental toxicant.
EU Classification
None required